Literature DB >> 1757939

Muscle pathology in ankylosing spondylitis: clinical, enzymatic, electromyographic and histologic correlation.

S Faus-Riera1, S Martínez-Pardo, J Blanch-Rubió, P Benito-Ruiz, J C Duró-Pujol, J M Corominas-Torres.   

Abstract

We assessed muscle pathology in 30 patients with ankylosing spondylitis (AS) and 22 controls to assess if skeletal muscle is affected primarily by the inflammatory process of the disease. Investigations included a questionnaire on musculoskeletal discomfort, physical exercises, dynamometric measurements, EMG, and biopsy of the quadriceps muscle. Symptoms of muscular weakness were related with enthesopathic activity index. Plasma CK was higher in patients than in controls. A myopathic EMG pattern was found in 46.4% patients. Histological changes were found in 66% and did not correlate with symptomatology. Patients with AS with clinical muscular manifestations probably have intense enthesopathic inflammatory activity. It is suggested that muscles are secondarily affected as a consequence of pain inhibition and reduced activity.

Entities:  

Mesh:

Year:  1991        PMID: 1757939

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Unusual association of systemic sclerosis and ankylosing spondylitis.

Authors:  Cinira S Soledade; Percival D Sampaio-Barros; Adil M Samara; João Francisco Marques-Neto
Journal:  Clin Rheumatol       Date:  2004-08-27       Impact factor: 2.980

2.  Decreased serum biochemical markers of muscle origin in patients with ankylosing spondylitis.

Authors:  E J Giltay; D van Schaardenburg; L J Gooren; P J Kostense; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  1999-09       Impact factor: 19.103

3.  Neurological complications of ankylosing spondylitis: neurophysiological assessment.

Authors:  Eman M Khedr; Sonia M Rashad; Sherifa A Hamed; Fatma El-Zharaa; Abdel Karim H Abdalla
Journal:  Rheumatol Int       Date:  2009-01-20       Impact factor: 2.631

4.  Respiratory muscle strength but not BASFI score relates to diminished chest expansion in ankylosing spondylitis.

Authors:  Günşah Sahin; Mukadder Calikoğlu; Cengiz Ozge; Nurgul Incel; Ali Biçer; Bahar Ulşubaş; Hayal Güler
Journal:  Clin Rheumatol       Date:  2004-03-16       Impact factor: 2.980

5.  Features of trunk muscle weakness in patients with ankylosing spondylitis: A cross-sectional study.

Authors:  Chin-Man Wang; Wei-Hsien Hong; Huei-Huang Ho; Ji-Yih Chen; Yu-Lin Tsai; Yu-Cheng Pei
Journal:  Biomed J       Date:  2019-05-07       Impact factor: 4.910

Review 6.  Muscle Evaluation in Axial Spondyloarthritis-The Evidence for Sarcopenia.

Authors:  Ana Valido; Carolina Lage Crespo; Fernando M Pimentel-Santos
Journal:  Front Med (Lausanne)       Date:  2019-10-18

7.  Reduced Appendicular Lean Body Mass, Muscle Strength, and Size of Type II Muscle Fibers in Patients with Spondyloarthritis versus Healthy Controls: A Cross-Sectional Study.

Authors:  Kristine Røren Nordén; Hanne Dagfinrud; Amund Løvstad; Truls Raastad
Journal:  ScientificWorldJournal       Date:  2016-09-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.